Chrysalis Ventures Names Richard Vance As Operating Partner

LOUISVILLE, KY (August 20, 2007) – Chrysalis Ventures, LLC, today announced that Richard Vance, former CEO and President of CorSolutions Medical, Inc., has been named an Operating Partner. Dr. Vance previously joined Chrysalis as Executive-in-Residence in February 2007. In his new role at Chrysalis, Dr. Vance will evaluate new business opportunities in the healthcare services and technology sector, assist current portfolio companies within this sector, and serve on the board of directors for select Chrysalis investments.

Dr. Vance has over 20 years of experience in healthcare IT, product development, health services research, and healthcare analytics and modeling, and has published more than 80 articles in national and industry publications. He was CEO and President of CorSolutions from 2001 to 2005, the nation’s second largest disease management company until it was acquired by Matria Healthcare. In 2004, Dr. Vance was recognized as one of the top 10 disease management executives by Managed Healthcare Magazine.

Prior to CorSolutions, Dr. Vance was Vice President for Population Health Improvement at Humana Inc., an internal consulting function which oversaw disease management program development and investments. Previously, he led Wake Forest University Medical Center’s Resource Utilization and Outcomes Management Department in the development of programs to improve efficiency for integrated delivery systems while also serving as Associate Professor of Pathology and as Associate Director of the Health Services Research Center.

Dr. Vance has a BA from Wake Forest University, an MA from University of Chicago, and a MD from Wake Forest University.

About Chrysalis Ventures
Founded in 1993, Chrysalis Ventures is a leading source of equity capital for young growth companies in the Midwest and South. Chrysalis invests primarily in early-stage and expansion-stage companies in healthcare services and technology, media and communications, and business services. Based in Louisville, Kentucky, Chrysalis has more than $300 million under management and has made investments in over 50 companies. For more information, please visit